Lennox International is in a recovery phase after a significant pullback, with the stock trading at $570.03 as of July 2, 2026, down 5.3% over the past year but up 14.3% year-to-date. The current price sits at 39% of its 52-week range ($434.06 low to $689.44 high), indicating it has recovered from the lows but remains well below the highs, suggesting a potential value opportunity if the recovery continues. The 1-year price change of -5.3% contrasts with the S&P 500's +19.1% gain, highlighting relative underperformance.

Short-term momentum is strong, with the stock gaining 10.4% in the past month and 25.4% in the past three months, significantly outpacing the S&P 500's 1-month and 3-month returns of -1.25% and 13.56%, respectively. This acceleration in momentum suggests a potential trend reversal from the prior downtrend, though the 1-year decline indicates that the recovery is still in its early stages. The relative strength versus the S&P 500 is positive over 1-month (+11.6%) and 3-month (+11.8%), confirming near-term outperformance.

Key support lies near the 52-week low of $434.06, while resistance is at the 52-week high of $689.44. A breakout above $689.44 would signal a resumption of the long-term uptrend, while a breakdown below $434.06 could indicate further downside. With a beta of 1.163, Lennox is slightly more volatile than the market, meaning it tends to amplify market moves by about 16%, which is important for risk management.

Lennox's revenue trajectory has been mixed, with the most recent quarter (Q4 2025) reporting revenue of $1.195 billion, a decline of 11.15% year-over-year from $1.345 billion in Q4 2024. This deceleration follows a pattern of slowing growth, as Q3 2025 revenue of $1.427 billion was down 4.8% from Q3 2024's $1.498 billion. The residential segment generated $699.8 million in Q4 2025, while commercial contributed $495.2 million, indicating that both segments are facing headwinds from softer new construction and replacement demand.

Profitability remains solid, with net income of $142.5 million in Q4 2025, though down from $197.7 million in the prior-year quarter. Gross margin improved slightly to 32.58% from 33.85% a year ago, while operating margin contracted to 16.38% from 18.19%, reflecting cost pressures. The net margin of 11.92% is still healthy but below the 14.70% reported in Q4 2024. The company has maintained positive net income for all recent quarters, with a trailing twelve-month net income of $786.2 million.

Balance sheet leverage is notable, with a debt-to-equity ratio of 1.77 and total debt to capitalization of 63.96%, indicating moderate financial risk. Free cash flow for the trailing twelve months was $638.8 million, providing ample coverage for debt service and dividends. The current ratio of 1.60 suggests adequate liquidity, while ROE of 67.6% is exceptionally high, driven by leverage and strong profitability. The company generated $405.9 million in operating cash flow in Q4 2025, supporting its ability to fund operations and invest in growth.